Related Experiment Videos
A case of two adverse reactions
1Friarage Hospital, Northallerton, UK. smithla@doctors.org.uk
Postgraduate Medical Journal
|August 10, 2004
Summary
Anaphylaxis from low molecular weight heparin is rare but serious. Patients may tolerate some heparins but react to others, requiring prompt adrenaline treatment.
Area of Science:
- Pharmacology
- Immunology
- Cardiology
Background:
- Low molecular weight heparins (LMWHs) are crucial in treating thromboembolic disorders and acute coronary syndromes.
- Anaphylaxis is a rare but severe adverse reaction to heparin therapy.
- Typical anaphylaxis symptoms include cardiovascular collapse, respiratory distress, and skin reactions.
Observation:
- This case highlights extremely severe anaphylactic reactions to LMWH, exceeding typical presentations.
- Individual patient responses vary; some may tolerate specific LMWHs while being hypersensitive to others.
- Adrenaline is the primary treatment for severe anaphylaxis.
Findings:
- Intramuscular adrenaline administration yields higher peak plasma concentrations than subcutaneous injection.
- This route is advantageous for critically ill patients requiring rapid drug delivery.
- UK Resuscitation Council guidelines recommend 0.5 ml of 1:1000 adrenaline intramuscularly for severe reactions.
Implications:
- Healthcare providers must be vigilant for rare but severe anaphylaxis to LMWHs.
- Understanding differential sensitivity to LMWH agents is critical for patient safety.
- Prompt intramuscular adrenaline administration is vital in managing severe heparin-induced anaphylaxis, especially in compromised patients.